YiLiu Assistant Secures RMB 10 Million in Angel Funding to Advance Oncology Patient Education and Care Management Platform
Jun 19, 2015 08:09
CST Updated
08:09
Recently, “Yi Liu Zhu Shou,” a mobile health platform specializing in oncology, announced the completion of its RMB 10 million angel financing round, led by Puhua Capital.
“OncoAssist” is positioned as China’s first comprehensive oncology care management service platform. In March this year, the public version of the “OncoAssist” app was launched. Under the professional guidance of the Chinese Society of Clinical Oncology (CSCO), it has taken the lead in advocating and promoting the systematic, specialized, and accessible development of patient education in oncology care across China. Through offline patient education activities and online dissemination, it helps patients better understand their disease, adhere to treatment and follow-up plans, thereby improving therapeutic outcomes.
According to CEO Zhang Zuo, the doctor version of the “OncoAssist” app will officially launch in July. At that time, it will onboard oncologists from multiple renowned Grade 3A hospitals in China through a real-name registration system. By integrating with the consumer-facing version of the app, it will provide systematic patient education, 24-hour doctor-patient communication, comprehensive disease management, and rehabilitation follow-up services for both doctors and patients, thereby fulfilling the company’s mission to “help doctors create efficiency and value, and bring hope and strength to patients.”
VCBeat has previously analyzed the domesticPatient Education Appcurrent landscape reveals that mobile health tools for patients primarily revolve around lightweight consultations, while patient education apps focused on bridging the communication gap between doctors and patients—caused by the highly specialized nature of medical knowledge—are extremely rare. The recent financing secured by “Yi Liu Zhu Shou” (Medical Oncology Assistant) indicates that deeply vertical sectors are also gaining market favor. VCBeat looks forward to seeing more patient education products enter the market.
“OncoAssist” is positioned as China’s first comprehensive oncology care management service platform. In March this year, the public version of the “OncoAssist” app was launched. Under the professional guidance of the Chinese Society of Clinical Oncology (CSCO), it has taken the lead in advocating and promoting the systematic, specialized, and accessible development of patient education in oncology care across China. Through offline patient education activities and online dissemination, it helps patients better understand their disease, adhere to treatment and follow-up plans, thereby improving therapeutic outcomes.
According to CEO Zhang Zuo, the doctor version of the “OncoAssist” app will officially launch in July. At that time, it will onboard oncologists from multiple renowned Grade 3A hospitals in China through a real-name registration system. By integrating with the consumer-facing version of the app, it will provide systematic patient education, 24-hour doctor-patient communication, comprehensive disease management, and rehabilitation follow-up services for both doctors and patients, thereby fulfilling the company’s mission to “help doctors create efficiency and value, and bring hope and strength to patients.”
VCBeat has previously analyzed the domesticPatient Education Appcurrent landscape reveals that mobile health tools for patients primarily revolve around lightweight consultations, while patient education apps focused on bridging the communication gap between doctors and patients—caused by the highly specialized nature of medical knowledge—are extremely rare. The recent financing secured by “Yi Liu Zhu Shou” (Medical Oncology Assistant) indicates that deeply vertical sectors are also gaining market favor. VCBeat looks forward to seeing more patient education products enter the market.